vit D is one of 116 small molecule programs targeting Rheumatoid Arthritis. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
744 competitors in Breast Cancer
Lexiscan
Voltaren
Duragesic-100
MS Contin
Duragesic
Sporanox
Tricor
Cortef
Vfend
vit D
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details